The National Agency for Food and Drug Administration and Control has denied the claims of efficacy of IHP Detox Tea for the cure of COVID-19 patients allegedly made by the Chief Executive Officer of Bioresources Development and Conservative Programme, Prof. Maurice Iwu.
It says the first stage of the clinical trial so far carried out on the product was not enough to confirm its efficacy until the Phase 3 Clinical Trial had been conducted with enough sample size.
The Director-General of NAFDAC, Prof. Mojisola Adeyeye says only NAFDAC has the mandate to make any pronouncement on the quality, safety, and efficacy of all regulated products that showed satisfactory scientific evidence.
She however explained that three herbal formulations were approved for clinical trial studies during the COVID-19 Pandemic.